Anand Parikh

Chief Executive Officer at FAETH THERAPEUTICS, INC.

Net worth: 20 M $ as of 29/06/2026

40 year

Consumer Services

Health Technology

Profile

Anand Parikh is the founder of Faeth Therapeutics LLC, founded in 2019, holding the titles of President, Chief Executive Officer & Director since 2026.
Mr. Parikh currently holds the position of Chairman, President & Chief Executive Officer at Faeth Therapeutics, Inc. since 2026.
Mr. Parikh completed undergraduate education at the University of Michigan and graduate education at New York University School of Law.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
FAETH THERAPEUTICS, INC. 3.17%	21/06/2026	817,699 ( 3.17% )	20 M $	29/06/2026

Anand Parikh active positions

Companies	Position	Start
FAETH THERAPEUTICS, INC.	Chief Executive Officer	12/06/2026
Faeth Therapeutics, Inc. Faeth Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops precision nutrition cancer treatment solutions which uses metabolism to starve cancer cells	Founder	31/03/2019

All active positions of Anand Parikh

Training of Anand Parikh

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Anand Parikh's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
University of Michigan University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
New York University School of Law New York University School of Law Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Faeth Therapeutics, Inc. Faeth Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops precision nutrition cancer treatment solutions which uses metabolism to starve cancer cells	Health Technology
Sensei Biotherapeutics, Inc. Sensei Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops immunotherapies for cancers and infectious disease	Health Technology